Analysis for Injective
Analysis summary
Injective (INJ) currently has a total score of 4 points, placing it in the very weak range. The score is made up of Performance (6), Stability (3) and Trend (2). All three sub-scores are currently below average.
Performance scores 6 points (very weak). Least weak metric: 3Y return at -28.6 %. Main drag: 1Y return at -78.9 %.
Stability scores 3 points (very weak). Least weak metric: return/volatility ratio at -0.74. Main drag: volatility (365d, annualized) at 106.2 %. That implies very high day-to-day swings. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 2 points (very weak). Trend signals are mostly negative right now. Least weak metric: trend strength at -0.84. Main drag: Price is about 36.2 % below SMA100.
Overall, the picture is very weak: none of the three dimensions shows a clear strength.
(Historical evaluation, not investment advice.)
Metrics
Stability
FAQ
- What investor type does Injective fit best in FoxScore?
- Injective looks fairly balanced in FoxScore: the sub-scores are close to each other. This often fits a diversified approach — then check the metrics (e.g., drawdowns/volatility) to see if they match your risk tolerance.
- How meaningful is the available history for Injective?
- Injective currently has about 5.3 years of price history since it started trading. This lets you judge how it behaved in its market phases since launch, but long-term conclusions across multiple cycles are naturally limited.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.